In:
Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 29, No. 6 ( 2009-06), p. 963-968
Abstract:
In healthy volunteers, oral treatment with rosuvastatin significantly augmented dipyridamole-induced vasodilation and prevented annexin A5 targeting to the ischemically exercised forearm. Both actions were inhibited by the adenosine receptor antagonist caffeine. These results provide for the first time pharmacological evidence that rosuvastatin augments extracellular formation of adenosine in humans in vivo.
Type of Medium:
Online Resource
ISSN:
1079-5642
,
1524-4636
DOI:
10.1161/ATVBAHA.108.179622
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2009
detail.hit.zdb_id:
1494427-3
Bookmarklink